Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • MJFF Research Grant, 2010
    PROGENI Family Study

    Objective/Rationale:
    The LRRK2 Consortium is designing studies to allow researchers to identify the key genetic, biological and clinical features of LRRK2 associated PD that could lead to improved...

  • Alpha-Synuclein Therapeutics, 2010
    Anti-amyloid Oligomer Monoclonal Antibodies for Treatment of Parkinson's Disease

    Objective/Rationale: 
    The goal of this project is to evaluate the interaction of a panel of conformation dependent, aggregation specific anti-amyloid monoclonal antibodies with alpha-synuclein...

  • Pharmacodynamic Biomarkers of LRRK2 Activity, 2010
    LRRK2 Dimerization as Pharmacodynamic Biomarkers of Activity

    Objective/Rationale: 
    A promising target for neuroprotective therapies in Parkinson’s disease has emerged in the LRRK2 protein kinase. Proteins with similarities to LRRK2 have been successfully...

  • Novel Hypotheses in Parkinson's Disease, 2010
    Quantitative Analysis of S-Nitrosylated Proteins in Parkinson's Disease

    Objective/Rationale: 
    Free radical stress may play a role in pathogenesis of Parkinson’s disease (PD).  In this project, we study how free radicals related to reactive nitrogen (N) and oxygen (O)...

  • Understanding LRRK2 Biology, 2010
    Functional Analysis of LRRK2: Focus on Autophagy

    Promising Outcomes of Original Grant:
    The overall purpose of the original grant was to utilize pre-clinical and human model systems to better understand LRRK biology. The original aims proposed were to...

  • Understanding LRRK2 Biology, 2010
    Biochemical characterization of full length human recombinant LRRK1 and LRRK2

    Promising Outcomes of Original Grant:
    In our initial application we proposed to take advantage of a lentiviral system recently developed in KULeuven to express full-length, soluble human LRRK1 and...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.